Moderna (MRNA)
Discover more about Moderna (MRNA), including the latest news, insights and features. Kiplinger has you covered for Moderna (MRNA) updates.
Latest
-
Stock Market Today 12/15/20: Nasdaq Hits Fresh Highs Ahead of Key Washington Meeting
Stock Market Today Stocks jumped ahead Tuesday ahead of a pivotal meeting of Congressional and White House leaders, who will try to hash out COVID stimulus and a spending bill.
By Kyle Woodley • Published
-
Stock Market Today 11/30/20: Dow Closes Out Best Month Since 1987
stocks The major indices dipped Monday despite more positive COVID vaccine news, but the Dow nonetheless capped its best single-month performance in 33 years.
By Kyle Woodley • Published
-
Stock Market Today 11/23/20: Stocks Start Another Week With a Vaccine Bump
stocks Equities rallied Monday after data showed high efficacy for an AstraZeneca (AZN) vaccine that could be more easily distributed than its peers.
By Kyle Woodley • Published
-
Stock Market Today 11/16/20: Dow 30,000 in Sight After Another Vaccine Rally
stocks Moderna (MRNA) followed up last week's Pfizer (PFE) act with outstanding vaccine data of its own, pushing the Dow to new highs just 50 points shy of 30,000.
By Kyle Woodley • Published
-
16 of the Most Popular Stocks Among Millennials
stocks We look at 16 of the most popular stocks among Millennials that have really captured widespread attention over the past few months.
By Charles Lewis Sizemore, CFA • Published
-
10 Health and Pharmaceutical Companies Fighting the COVID-19 Coronavirus
stocks Coronavirus fears have triggered volatility, a correction and ultimately a bear market in U.S.
By Lisa Springer • Last updated
-